Prime Minister: India to be at centre of global healthcare effort

In his virtual keynote address at the Grand Challenges Annual Meeting, Modi said India is now at the forefront of vaccine development for COVID-19 and that some of the vaccine candidates are in advanced stages of the trial.

With India’s experience and research talent, the country will be at “the centre of global healthcare effort” and will want to help other nations, he said, noting that more than 60 per cent of vaccines used for global immunisation programmes are produced here. India has proven capacity for producing quality medicines and vaccine at low cost, he said. Speaking of the country’s efforts for immunisation of its citizens against COVID-19, he said India is already working on putting a robust vaccine delivery system in place and its digitised network, along with the new digital health ID, will be used to ensure its success. “Today, we are seeing a decline in the number of daily cases and the growth rate of cases. India has one of the highest recovery rates of 88 per cent,” Modi said.

 “In India, we have a strong and vibrant scientific community. We also have very good scientific institutions. They have been India’s greatest assets, especially during the last several few months, while fighting COVID19. From containment to capacity building, they have achieved wonders,” he added. India was one of the first countries to adopt a flexible lockdown when there were only a few hundreds of total cases and also was one of the first to encourage the use of face masks, he noted. 

India actively began to work on effective contact-tracing and was one of the earliest to deploy the rapid antigen tests, he said. While stressing that future will be shaped by societies that invest in science and innovation, the prime minister cautioned that this cannot be done in a short-sighted manner and one has to invest in science and innovation well in advance. That is when we can reap benefits at the right time, he said.